Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Methylprednisolone After Thrombectomy in Stroke
NCT07141303Phase 3Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone sodium succinate in ischemic stroke, sponsored by Tangdu Hospital. Started Aug 2025; status: recruiting.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07141303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07141303.